News

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
Terry Smith slammed two of Denmark’s largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they ...
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...
Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in ...
GAMMA Investing LLC increased its stake in Eli Lilly by 25.8%, now holding 18,000 shares valued at nearly $15 million. This ...
Eli Lilly One of the biggest healthcare companies in the world, Eli Lilly is known for its weight loss drugs. The company has a market cap of $729 billion and the stock is exchanging hands for $769.